Oppenheimer & Co’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,400
Closed -$110K 1320
2016
Q2
$110K Sell
10,400
-900
-8% -$10.2K ﹤0.01% 1161
2016
Q1
$149K Hold
11,300
﹤0.01% 1151
2015
Q4
$113K Sell
11,300
-3,500
-24% -$33.8K ﹤0.01% 1199
2015
Q3
$100K Buy
14,800
+1,300
+10% +$10.8K ﹤0.01% 1265
2015
Q2
$150K Buy
13,500
+2,000
+17% +$26.7K ﹤0.01% 1364
2015
Q1
$157K Buy
+11,500
New +$171K ﹤0.01% 1365
2014
Q1
Sell
-5,609
Closed -$339K 1495
2013
Q4
$339K Buy
+5,609
New +$304K 0.01% 965
2013
Q3
Sell
-8,762
Closed -$540K 1386
2013
Q2
$540K Buy
+8,762
New +$370K 0.02% 694

Other funds holding XONE

Oppenheimer & Co's XONE Position: Q3 2016 in Review

Oppenheimer & Co sold out of The ExOne Company (XONE) in Q3 2016, closing a stake of 10,400 shares — an estimated $110K sold.

Oppenheimer & Co first reported a position in XONE in Q2 2013 and held it in 8 quarters. The position peaked at $540K in Q2 2013. 73 funds tracked by Wall St. Rank hold XONE as of Q3 2016.

  • Oppenheimer & Co reported no remaining The ExOne Company position as of Q3 2016 after selling out during the quarter.
  • Oppenheimer & Co sold 10,400 The ExOne Company shares in Q3 2016, an estimated $110K.
  • Oppenheimer & Co first reported a position in The ExOne Company in Q2 2013 and held it in 8 quarters.
  • Oppenheimer & Co's The ExOne Company position peaked at $540K in Q2 2013.
  • 73 funds tracked by Wall St. Rank held The ExOne Company as of Q3 2016.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.